Guadalquiver, Jean .

HRN: 25-99-96  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/02/2024
10/09/2024
IV
330
Q8h
T/c Generalized Tetanus
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Central Nervous System    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: